Literature DB >> 10350369

Euphorbia hirta leaf extracts increase urine output and electrolytes in rats.

P B Johnson1, E M Abdurahman, E A Tiam, I Abdu-Aguye, I M Hussaini.   

Abstract

Euphorbia hirta is locally used in Africa and Australia to treat numerous diseases, including hypertension and edema. The diuretic effect of the E. hirta leaf extracts were assessed in rats using acetazolamide and furosemide as standard diuretic drugs. The water and ethanol extracts (50 and 100 mg/kg) of the plant produced time-dependent increase in urine output. Electrolyte excretion was also significantly affected by the plant extracts. The water extract increased the urine excretion of Na+, K+ and HCO3-. In contrast, the ethanol extract increased the excretion of HCO3- decreased the loss of K+ and had little effect on renal removal of Na+. Acetazolamide, like the water extract, increased urine output and enhanced the excretion of Na+, K+ and HCO3-. The high-ceiling diuretic, furosemide, increased the renal excretion of Na+ and Cl-; but had no effect on K+ and HCO3- loss. This study suggests that the active component(s) in the water extract of E. hirta leaf had similar diuretic spectrum to that of acetazolamide. These results validate the traditional use of E. hirta as a diuretic agent by the Swahilis and Sukumas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350369     DOI: 10.1016/s0378-8741(98)00143-3

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  15 in total

1.  A molecular pharmacology study into the anti-inflammatory actions of Euphorbia hirta L. on the LPS-induced RAW 264.7 cells through selective iNOS protein inhibition.

Authors:  Mei-Fen Shih; Yih-Dih Cheng; Chia-Rui Shen; Jong-Yuh Cherng
Journal:  J Nat Med       Date:  2010-07       Impact factor: 2.343

2.  Creosote bush (Larrea tridentata) resin increases water demands and reduces energy availability in desert woodrats (Neotoma lepida).

Authors:  Antonio M Mangione; M Denise Dearing; William H Karasov
Journal:  J Chem Ecol       Date:  2004-07       Impact factor: 2.626

3.  Euphorbia hirta reverses chronic stress-induced anxiety and mediates its action through the GABA(A) receptor benzodiazepine receptor-Cl(-) channel complex.

Authors:  H Anuradha; B N Srikumar; B S Shankaranarayana Rao; M Lakshmana
Journal:  J Neural Transm (Vienna)       Date:  2007-12-18       Impact factor: 3.575

4.  Euphorbia hirta: Its chemistry, traditional and medicinal uses, and pharmacological activities.

Authors:  Sunil Kumar; Rashmi Malhotra; Dinesh Kumar
Journal:  Pharmacogn Rev       Date:  2010-01

5.  Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus.

Authors:  Cheryl A Lans
Journal:  J Ethnobiol Ethnomed       Date:  2006-10-13       Impact factor: 2.733

6.  Acute and subchronic toxicity study of Euphorbia hirta L. methanol extract in rats.

Authors:  Kwan Yuet Ping; Ibrahim Darah; Yeng Chen; Subramaniam Sreeramanan; Sreenivasan Sasidharan
Journal:  Biomed Res Int       Date:  2013-12-10       Impact factor: 3.411

7.  Acute toxicity impacts of Euphorbia hirta L extract on behavior, organs body weight index and histopathology of organs of the mice and Artemia salina.

Authors:  Mohammad Abu Basma Rajeh; Yuet Ping Kwan; Zuraini Zakaria; Lachimanan Yoga Latha; Subramanion L Jothy; Sreenivasan Sasidharan
Journal:  Pharmacognosy Res       Date:  2012-07

8.  Ethnomedicines used in Trinidad and Tobago for reproductive problems.

Authors:  Cheryl Lans
Journal:  J Ethnobiol Ethnomed       Date:  2007-03-15       Impact factor: 2.733

9.  The effects of Euphorbia hirta on the ultrastructure of the murine liver, kidney and aorta.

Authors:  J Y R Wong; Y S Chen; S Chakravarthi; J P Judson; Santhana Raj L; H M Er
Journal:  Exp Ther Med       Date:  2013-09-13       Impact factor: 2.447

10.  Chemical analysis, inhibition of biofilm formation and biofilm eradication potential of Euphorbia hirta L. against clinical isolates and standard strains.

Authors:  Shanmugapriya Perumal; Roziahanim Mahmud
Journal:  BMC Complement Altern Med       Date:  2013-12-09       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.